Mirum(MIRM) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Mirum Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update – Second quarter 2025 total revenue of $128 million – 2025 revenue guidance increased to $490 to $510 million – Conference call to provide business updates today, August 6 at 1:30 p.m. PT / 4:30 p.m. ET FOSTER CITY, Calif. – August 6, 2025 - Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the second quarter 2025 and provided a business update. "Our second quarter resu ...